Literature DB >> 10869386

Evaluation of a minimal experimental design for determination of enzyme kinetic parameters and inhibition mechanism.

T Kakkar1, Y Pak, M Mayersohn.   

Abstract

The advent of combinatorial chemistry has led to a deluge of new chemical entities whose metabolic pathways need to be determined. A significant issue involves determination of the ability of new agents to inhibit the metabolism of existing drugs as well as its own susceptibility for altered metabolism. There is need to estimate the enzyme inhibition parameters and mechanism or mechanisms of inhibition with minimal experimental effort. We examined a minimal experimental design for obtaining reliable estimates of K(i) (and V(max) and K(m)). Simulations have been applied to a variety of experimental scenarios. The least experimentally demanding case involved three substrate concentrations, [S], for the control and one substrate-inhibitor pair, [S]-[I]. The control and inhibitor data (with 20% coefficient of variance random error) were simultaneously fit to the full nonlinear competitive inhibition equation [simultaneous nonlinear regression (SNLR)]. Excellent estimates of the correct kinetic parameters were obtained. This approach is clearly limited by the a prior assumption of mechanism. Further simulations determined whether SNLR would permit assessment of the inhibition mechanism (competitive or noncompetitive). The minimal design examined three [S] (control) and three [S]-[I] pairs. This design was successful in identifying the correct model for 98 of 100 data sets (20% coefficient of variance random error). SNLR analysis of metabolite formation rate versus [S] permits a dramatic reduction in experimental effort while providing reliable estimates of K(i), K(m), and V(max) along with an estimation of the mechanism of inhibition. The accuracy of the parameter estimates will be affected by the experimental variability of the system under investigation.

Mesh:

Substances:

Year:  2000        PMID: 10869386

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  10 in total

1.  σ-1 receptor at the mitochondrial-associated endoplasmic reticulum membrane is responsible for mitochondrial metabolic regulation.

Authors:  Karla-Sue C Marriott; Manoj Prasad; Veena Thapliyal; Himangshu S Bose
Journal:  J Pharmacol Exp Ther       Date:  2012-08-24       Impact factor: 4.030

2.  Identification of inhibitor concentrations to efficiently screen and measure inhibition Ki values against solute carrier transporters.

Authors:  Xiaowan Zheng; James Polli
Journal:  Eur J Pharm Sci       Date:  2010-05-27       Impact factor: 4.384

3.  High-throughput screening for human lysosomal beta-N-Acetyl hexosaminidase inhibitors acting as pharmacological chaperones.

Authors:  Michael B Tropak; Jan E Blanchard; Stephen G Withers; Eric D Brown; Don Mahuran
Journal:  Chem Biol       Date:  2007-02

4.  Caffeine enhances myocardial uptake of idarubicin but reverses its negative inotropic effect.

Authors:  Wonku Kang; Michael Weiss
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-23       Impact factor: 3.000

5.  The basis for non-canonical ROK family function in the N-acetylmannosamine kinase from the pathogen Staphylococcus aureus.

Authors:  David Coombes; James S Davies; Michael C Newton-Vesty; Christopher R Horne; Thanuja G Setty; Ramaswamy Subramanian; James W B Moir; Rosmarie Friemann; Santosh Panjikar; Michael D W Griffin; Rachel A North; Renwick C J Dobson
Journal:  J Biol Chem       Date:  2020-01-15       Impact factor: 5.157

6.  α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure-activity relationship study.

Authors:  Carina Proença; Marisa Freitas; Daniela Ribeiro; Eduardo F T Oliveira; Joana L C Sousa; Sara M Tomé; Maria J Ramos; Artur M S Silva; Pedro A Fernandes; Eduarda Fernandes
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

7.  Dealing with aflatoxin B1 dihydrodiol acute effects: Impact of aflatoxin B1-aldehyde reductase enzyme activity in poultry species tolerant to AFB1 toxic effects.

Authors:  Hansen Murcia; Gonzalo J Diaz
Journal:  PLoS One       Date:  2020-06-22       Impact factor: 3.240

8.  Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice.

Authors:  Y Kapelyukh; C J Henderson; N Scheer; A Rode; C R Wolf
Journal:  Drug Metab Dispos       Date:  2019-05-30       Impact factor: 3.922

9.  Insight into the Mechanism of Phenylacetate Decarboxylase (PhdB), a Toluene-Producing Glycyl Radical Enzyme.

Authors:  Andria V Rodrigues; Dean J Tantillo; Aindrila Mukhopadhyay; Jay D Keasling; Harry R Beller
Journal:  Chembiochem       Date:  2019-11-07       Impact factor: 3.164

10.  Biotransformation of Polycyclic Aromatic Hydrocarbons by Trout Liver S9 Fractions: Evaluation of Competitive Inhibition Using a Substrate Depletion Approach.

Authors:  John W Nichols; Melanie A Ladd; Alex D Hoffman; Patrick N Fitzsimmons
Journal:  Environ Toxicol Chem       Date:  2019-11-05       Impact factor: 4.218

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.